Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid during open prostatectomy for bleeding reduction
IRCT20180625040232N8Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of tranexamic acid in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoints: Hemoglobin level and Length of hospital stay. Started Apr 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20180625040232N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180625040232N8.